Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 5.09 · gapped above the open, then crossed back over prior close. High/low 5.24 at 7:30 am ET, 5.05 at 1:30 pm ET.
Embecta Corp.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Surgical & Medical Instruments & Apparatus
Each disclosed tie as a share of both companies’ annual revenue. The bigger share is the side that would feel it if the relationship ended.
| Partner | % of their revenue | % of EMBC revenue | Skew |
|---|---|---|---|
| CAHCardinal Health | 0.06% | 14.00% | 235× |
| MCKMcKesson Corporation | 0.04% | 14.00% | 373× |
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“For example, for the fiscal year ended September 30, 2025, gross sales to Cencora, McKesson Corporation, and Cardinal Health, Embecta's three largest distributors, together represented approximately 42% of Embecta's worldwide gross sales.”
$151M relationship235× more of EMBC’s book than CAH’s
basisEMBC fy2025 · closed 2025-09 $1.1BCAH fy2026 · closed 2026-06 $254B
The two fiscal years close in different months, so the derived share compares periods that do not line up exactly.
FILING10-K0001872789-25-000036cik 0001872789
“For example, for the fiscal year ended September 30, 2025, gross sales to Cencora, McKesson Corporation, and Cardinal Health, Embecta's three largest distributors, together represented approximately 42% of Embecta's worldwide gross sales.”
$151M relationship373× more of EMBC’s book than MCK’s
basisEMBC fy2025 · closed 2025-09 $1.1BMCK fy2026 · closed 2026-03 $403B
The two fiscal years close in different months, so the derived share compares periods that do not line up exactly.
“For example, for the fiscal year ended September 30, 2025, gross sales to Cencora, McKesson Corporation, and Cardinal Health, Embecta's three largest distributors, together represented approximately 42% of Embecta's worldwide gross sales.”
$151M relationship
basisEMBC fy2025 · closed 2025-09 $1.1B
FILING10-K0001872789-25-000036
“In addition, for the fiscal year ended September 30, 2025, direct gross sales to the five largest retail pharmacies for Embecta's products together represented approximately 14% of Embecta's worldwide gross sales.”
$151M relationship
basisEMBC fy2025 · closed 2025-09 $1.1B
FILING10-K0001872789-25-000036
“For example, in connection with the Separation and prior to the distribution, Embecta and BD entered into a cannula supply agreement, whereby BD sells to Embecta cannulas for incorporation into Embecta's products for sale within the diabetes care sector.”
FILING10-K0001872789-25-000036cik 0001872789
Watchlist prices, news filtered to it, and its next report on your desk.
FILING10-K0001872789-25-000036cik 0001872789
Embecta Corp. has 1 disclosed supplier and 4 disclosed customers. Each one is named in an SEC filing, either Embecta Corp.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
EMBC (Embecta Corp.) has 1 disclosed suppliers and 4 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: BDX +1.56%, in healthcare.